Completed OBSERVATIONAL NCT00291421

A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease

International Outcomes Survey In Dementia (IOSID)

Sponsor: Janssen Pharmaceutica N.V., Belgium

Conditions Alzheimer Disease Brain Diseases Dementia Mental Disorders Nervous System Diseases

Updated 6 times since 2017 Last updated: Apr 15, 2013 Started: Jul 31, 2002 Completion: May 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Alzheimer Disease and Brain Diseases, this trial is completed. The trial is conducted by Janssen Pharmaceutica N.V., Belgium and has accumulated 6 data snapshots since 2002. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jul 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Janssen Pharmaceutica N.V., Belgium

Data source: Janssen Pharmaceutica N.V., Belgium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.